NASDAQ
KRMD
Last Price
US $3.33
Valuation
Financial
Performance
Cash flow to debt coverage
KORU Medical Systems, Inc. cash flow to debt ratio of 13.23% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
KORU Medical Systems, Inc.'s free cash flow has increased -70.93% from $-1.62M last year to $-470.11K, signaling increasing performance
Debt-to-equity ratio
KORU Medical Systems, Inc.'s debt to equity ratio is 0.18, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
KORU Medical Systems, Inc.'s debt has decreased relative to shareholder equity from 0.24 last year to 0.18 today, signaling strengthened financials
Net debt to EBITDA
KORU Medical Systems, Inc. has a net cash position, so leverage is healthy.
Interest coverage
KORU Medical Systems, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Profit margin growth
KORU Medical Systems, Inc.'s profit margin has increased (-77.63%) in the last year from -18.03% to -4.03%, signaling increasing performance
Current ratio
KORU Medical Systems, Inc.'s short-term assets of $19.99M exceed its short-term liabilities of $8.19M
Return on assets
KORU Medical Systems, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
KORU Medical Systems, Inc.'s return on equity of -10.63%, is lower than 15.00%, indicating bad performance
Earnings quality
KORU Medical Systems, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
KORU Medical Systems, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings
Positive free cash flow
KORU Medical Systems, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
KORU Medical Systems, Inc. has negative free cash flow, indicating cash burn
Earnings growth
KORU Medical Systems, Inc.'s yearly earnings has increased -56.52% since last year from $-6.07M to $-2.64M, signaling increasing performance
Revenue growth
KORU Medical Systems, Inc.'s yearly revenue has increased 22.24% since last year from $33.65M to $41.13M, signaling increasing performance
Return on invested capital
ROIC -7.74% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
KORU Medical Systems, Inc.'s 3-year revenue CAGR of 13.81% is positive, indicating growing revenue over the past 3 years
Revenue consistency
KORU Medical Systems, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance
Return on equity consistency
KORU Medical Systems, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity
Cash Flow Valuation (DCF)
KORU Medical Systems, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
KORU Medical Systems, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
KORU Medical Systems, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
KORU Medical Systems, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
KORU Medical Systems, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
KORU Medical Systems, Inc. has a price-to-book ratio of 8.68x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Price-to-sales ratio (TTM)
KORU Medical Systems, Inc. has a price-to-sales ratio of 3.47x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-10.63%
Return on equity
ROIC: -7.74%
Valuation History
-
Price to Earnings
EV/EBITDA: -145.1X
Cash flow
Profit margin
-
Cash flow
30.87%
Fair Value
Market $3.33
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.